BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

J & J Single-Shot COVID-19 Vaccine shows Positive Data Against Delta Variant

Demonstrated strong neutralizing antibody activity against the Delta (B.1.617.2) variant Persistent immune responses through at least eight months Jo...

July 04, 2021 | News

Clover Announces Advance Purchase Agreement with Gavi

Clover Biopharmaceuticals (Clover), a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutic candidates to address ...

June 30, 2021 | News

India cleared the 4th vaccine for emergency use in the country, the US-made Moderna.

Mumbai-based pharma major Cipla has been allowed to import Moderna's Covid vaccine for restricted emergency use in India, where the vaccines used so far we...

June 30, 2021 | News

Duke-NUS and GenScript notice of allowance for U.S. patent application for SARS-CoV-2 surrogate virus neutralisation test

Developed by Professor Linfa Wang and his team from Duke-NUS, the sVNT neutralization antibody detection technology is exclusively licensed to Ge...

June 25, 2021 | News

Eurofins Discovery Expand their Antibody Discovery Platform

Eurofins Discovery's global clients will have access to ImmunoPrecise's end-to-end antibody discovery capabilities using wild type and best-in-class i...

June 23, 2021 | News

Phase III Clinical Trial of BIOKANGTAI COVID-19 Vaccine Initiated in Malaysia

On June 21, local time, phase III clinical fieldwork of the Inactivated COVID-19 Vaccine (Vero cells) independently developed and manufactured by Shen...

June 23, 2021 | News

Thermo Fisher Scientific Launches CE-IVD-Marked Next-Generation TaqPath COVID-19 2.0 Test

Thermo Fisher Scientific, the world leader in serving science, today announced the launch of a new CE-IVD-marked COVID-19 test. The TaqPath COVID-19 Fast P...

June 22, 2021 | News

Cambodia's MHDC approved INDICAID(R) COVID-19 Rapid Antigen Test

Rapid antigen tests like INDICAID® have been deployed by the Cambodian Government for widescale screening measures in the capital city Phnom Penh&...

June 22, 2021 | News

Fujitsu Japan & UOT Embarks on Joint Research for COVID-19 Therapies

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using World's Fastest Supercomputer with Researchers of Research Center for Advanced Science...

June 22, 2021 | News

Oxygen saturation level in covid-19, the forerunner of crisis

As per norms. If the oxygen saturation is 94% or lower, the patient needs immediate attention. Saturation of less than 90% is a clinical emergency. Pulse-O...

June 21, 2021 | Opinion

MSD Announces Supply Agreement with U.S. Govt. for Molnupiravir

Merck (NYSE: MRK), known as MSD outside the United States and Canada, today announced it has entered into a procurement agreement with&...

June 21, 2021 | News

Qiagen presents qiacuity One-Step Viral RT-PCR systems

Technology allows measuring average infected, possible variants and guiding the taking of preventive measures from the presence of the virus in sewage ...

June 20, 2021 | News

Roche SARS-CoV-2 molecular test granted first FDA Emergency Use

This is the first SARS-CoV-2 real-time RT-PCR test authorised for use in screening and testing asymptomatic and symptomatic individuals with results wi...

June 19, 2021 | News

Manufacturing Strategies for mRNA Vaccines and Therapeutics

In contrast, non-viral delivery systems are expected to have a better safety profile and with simplified manufacturing, offer the potential for a templated...

June 18, 2021 | News | By Nargisse El Hajjami, Dr1, Manuel Brantner, Mag.2, Anissa Boumlic, Dr3, Shiksha Mantri, 4, Bahar Cebi, 5 1Associate Director Cell and Gene Therapy Segment EMEA, 2Associate Director Vaccine and Plasma Segment EMEA, 3Head of Global Vaccine & Plasma Segments

Stay Connected